The Analyst Verdict: Werewolf Therapeutics In The Eyes Of 4 Experts
The Analyst Verdict: Werewolf Therapeutics In The Eyes Of 4 Experts
分析師的判決：4位專家眼中的狼人療法
Werewolf Therapeutics (NASDAQ:HOWL) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在過去的三個月中，有4位分析師對狼人療法（納斯達克股票代碼：HOWL）進行了分析，揭示了從看漲到看跌的不同觀點。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表簡要概述了他們最近的評級，重點介紹了過去30天中情緒的變化，並將其與前幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $13.5, a high estimate of $15.00, and a low estimate of $12.00. A decline of 10.0% from the prior average price target is evident in the current average.
分析師12個月目標股價的見解已經公佈，平均目標股價爲13.5美元，最高估計爲15.00美元，低估值爲12.00美元。目前的平均價格比先前的平均目標股價下降了10.0％。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細明細
A clear picture of Werewolf Therapeutics's...
通過對分析師近...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。